A substantially dry nonwoven pad is provided containing a formulation comprising nicotinamide in an amount between about 1% to about 10% w/w based on the total weight of the formulation and at least one water-soluble gritty polymer in an amount between about 10% to about 75% w/w based on the total weight of the formulation. The nicotinamide-containing pad is used topically for treatment of skin inflammation, in one easy step. In a method for treating skin inflammation, including acne, rosacea, and acne scars (hyperpigmentation), the nicotinamide-containing pad is moistened, then applied to the skin treatment area using gentle scrubbing, followed by rapid absorption of the formulation by the skin, and rinsing the skin with water.
